Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-009836
Filing Date
2025-03-28
Accepted
2025-03-28 16:02:19
Documents
5
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A aytu20250213_def14a.htm DEF 14A 834398
2 aytu_page1.jpg GRAPHIC 167240
3 aytu_page2.jpg GRAPHIC 137795
4 cgraph.jpg GRAPHIC 73688
5 pgraph.jpg GRAPHIC 74440
  Complete submission text file 0001437749-25-009836.txt   1460025
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 25785832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)